Sensorium Therapeutics

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

38 Wareham St, Boston, Massachusetts, 02...

Revenue

$6.8 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1

About Sensorium Therapeutics

Sensorium Therapeutics is a clinical-stage biotech company using AI-driven discovery to develop innovative, nature-inspired treatments for brain and mental health disorders, including anxiety, epilepsy, and Alzheimer's disease.Explore more
Sensorium Therapeutics's Social MediaPopular SearchesSensorium TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Sensorium Therapeutics Org Chart

PhoneEmail
Rolando Gutierrez-Esteinou, Chief Medical Officer at Sensorium Therapeutics
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AP
United States flag for contact location.

Neurobiology Senior Research Associate

PhoneEmail
AL
United States flag for contact location.

Senior Research Associate

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Sensorium Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Sensorium Therapeutics

Compare insights from companies similar to Sensorium Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Sensorium Therapeutics

$6.8M
11-50
Private
$55M
2021
Rolando Gutierrez-Esteinou, Chief Medical Officer at Sensorium Therapeutics
Rolando Gutierrez-Esteino...Chief Medical Officer
$5.1M
11-50
Private
$140M
2020
Darlene Deptula-Hicks, Chief Financial Officer at Normunity
Darlene Deptula-HicksChief Financial Officer
<$5M
1-10
Private
-
-
TF
Tom FayCo-Founder & CEO
<$5M
1-10
Private
$163M
2008
Gregory Mayes, President & Chief Executive Officer at Reunion Neuroscience
Gregory MayesPresident & CEO
<$5M
11-50
Private
$108M
2019
Mark Rus, Chief Executive Officer & Director at Delix Therapeutics
Mark RusCEO & Director
<$5M
1-10
Private
$16.5M
2014
VS
Vincent SandanayakaFounder & President, CSO
1-10
Public
<$5M
2020
Daniel Schneiderman, Chief Financial Officer at Pasithea Therapeutics
Daniel SchneidermanChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Sensorium Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Sensorium Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sensorium Therapeutics.

Sensorium Therapeutics financials insights

Gather financial insights about Sensorium Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2022

Series A

$30M

2025

Series A

$25M

See All Sensorium Therapeutics's Financials Insights

Sensorium Therapeutics Tech Stack

A closer look at the technologies used by Sensorium Therapeutics

Most Recent Scoops

Funding
Funding
Project
Research & Development, Product Management, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Board of Directors
See more scoops

Sensorium Therapeutics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Sensorium Therapeutics

What is Sensorium Therapeutics's official website?
Sensorium Therapeutics's official website is sensorium.bio
What is Sensorium Therapeutics's Revenue?
Sensorium Therapeutics's revenue is $6.8 Million
What is Sensorium Therapeutics's SIC code?
Sensorium Therapeutics's SIC: 28,283
What is Sensorium Therapeutics's NAICS code?
Sensorium Therapeutics's NAICS: 32,325
How many employees does Sensorium Therapeutics have?
Sensorium Therapeutics has 11-50 employees
What industry does Sensorium Therapeutics belong to?
Sensorium Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Sensorium Therapeutics competition?
Sensorium Therapeutics top competitors include: Normunity, Delix Therapeutics, Nirogy Therapeutics, Pasithea Therapeutics
What technology does Sensorium Therapeutics use?
Some of the popular technologies that Sensorium Therapeutics uses are: Cloudflare CDN, Squarespace Online Stores, Adobe Typekit, Google Global Site Tag
What does Sensorium Therapeutics do?

Sensorium Therapeutics is a clinical-stage biotech company using AI-driven discovery to develop innovative, nature-inspired treatments for brain and mental health disorders, including anxiety, epilepsy, and Alzheimer's disease.... Read More

What are Sensorium Therapeutics social media links?
Sensorium Therapeutics Linkedin page Sensorium Therapeutics Twitter page
Who invested in Sensorium Therapeutics?
Sensorium Therapeutics has 7 investors including Mockingbird Credit Partners, Santé Ventures, Route 66 Ventures and CU Healthcare Innovation Fund.
Is Sensorium Therapeutics a public company?
Sensorium Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Sensorium Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.